Skip to main navigation
Skip to search
Skip to main content
Sort by
Keyphrases
Potent Inhibitor
100%
P38 Mitogen-activated Protein Kinase (p38 MAPK)
100%
Inflammatory Hyperalgesia
100%
Targeted Compounds
100%
Inhibitory Activity
40%
Inflammatory Pain
40%
Mouse Model
20%
Tumor Necrosis Factor-α
20%
Intrathecal Injection
20%
Signal Transduction
20%
Neuropathic Pain
20%
IC50 Value
20%
G Protein
20%
Human Monocytes
20%
Inflammatory Mediators
20%
Lipopolysaccharide-induced
20%
Hyperalgesia
20%
Phenyl Ring
20%
Lysozyme
20%
THP1
20%
MAPK Inhibitors
20%
In Vivo Effects
20%
GRK2
20%
Virtual Screening
20%
Chloride
20%
Benzo
20%
Analgesic Effect
20%
Long-lasting Effect
20%
Methyl Groups
20%
Docking Site
20%
Persistent Pain
20%
Activity Assay
20%
Oxadiazole
20%
SB239063
20%
Targeted Inhibitors
20%
Post-inflammatory
20%
Medicine and Dentistry
p38 Mitogen-Activated Protein Kinase
100%
Hyperpathia
100%
Inflammatory Pain
40%
Intrathecal Drug Administration
20%
IC50
20%
Phosphotransferase
20%
Neuropathic Pain
20%
Mediator
20%
Lipopolysaccharide
20%
Mitogen Activated Protein Kinase P38
20%
Guanine Nucleotide Binding Protein
20%
Secretion (Process)
20%
Tumor Necrosis
20%
Signal Transduction
20%
Lysozyme
20%
Analgesic Activity
20%
Virtual Screening
20%
Persistent Pain
20%
4 [4 (4 Fluorophenyl) 5 (2 Methoxy 4 Pyrimidinyl) 1 Imidazolyl]cyclohexanol
20%
Methyl Group
20%
Inflammation
20%
Monocyte
20%
Chloride
20%
Pharmacology, Toxicology and Pharmaceutical Science
Hyperalgesia
100%
Inflammatory Pain
50%
Phosphotransferase
25%
Mouse Model
25%
Intrathecal
25%
Analgesic Agent
25%
IC50
25%
Inflammation
25%
Neuropathic Pain
25%
Lipopolysaccharide
25%
Mitogen Activated Protein Kinase P38
25%
Guanine Nucleotide Binding Protein
25%
Tumor Necrosis
25%
Virtual Screening
25%
Lysozyme
25%
Methyl Group
25%
4 [4 (4 Fluorophenyl) 5 (2 Methoxy 4 Pyrimidinyl) 1 Imidazolyl]cyclohexanol
25%
Chloride
25%